Rakuten Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Rakuten Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.4M	Buy	52,690 +5,505	+12%	+$2.57M	0.05%	75
2025 Q4	$21.7M	Sell	47,185 -195,277	-81%	-$84.2M	0.07%	88
2025 Q3	$24.1M	Buy	+242,462	New	+$101M	0.09%	64
2025 Q1	$16.2M	Buy	+32,871	New	+$15.3M	0.07%	68
2024 Q3	$9.49M	Buy	20,495 +5,267	+35%	+$2.53M	0.06%	64
2024 Q2	$7.2M	Buy	15,228 +5,821	+62%	+$2.53M	0.05%	61
2024 Q1	$3.93M	Buy	9,407 +8,770	+1,377%	+$3.71M	0.03%	70
2023 Q4	$261K	Buy	+637	New	+$235K	﹤0.01%	90

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rakuten Investment Management's VRTX Position: Q1 2026 in Review

Rakuten Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, buying an estimated $2.57M and bringing the position to 52,690 shares worth $23.4M. The position accounts for 0.05% of the portfolio, ranked #75.

Rakuten Investment Management first reported a position in VRTX in Q4 2023 and has held it in 8 quarters since. The position peaked at $24.1M in Q3 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Rakuten Investment Management held 52,690 shares of Vertex Pharmaceuticals worth $23.4M as of Q1 2026.
Rakuten Investment Management bought 5,505 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.57M.
Vertex Pharmaceuticals made up 0.05% of Rakuten Investment Management's portfolio in Q1 2026, its #75 holding.
Rakuten Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
Rakuten Investment Management's Vertex Pharmaceuticals position peaked at $24.1M in Q3 2025.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.